I

Intellikine Inc

3 employees

Intellikine is focused on the R&D of orally available small molecule drugs targeting the PI3K/mTOR pathway.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Medical

Date founded

2007

Funding rounds raised

Total raised

$51M

from 5 investors over 5 rounds

I

Intellikine Inc raised $51M on July 22, 2009

Investors: CMEA Capital, Abingworth, Biogen Idec and Sofinnova Ventures, Russia technology fund

I

Intellikine Inc raised $30M on June 1, 2007

Investors: Sofinnova Ventures, Russia technology fund

FAQ